[1] | Ezenwaka CE, Offiah NV. Cardiovascular risk of obese and non-obese patients with type 2 diabetes in the West Indies. J Biomed Sci 8(4): 314-320, 2001. |
[2] | Ezenwaka CE, Offiah NV. Abdominal obesity in Type 2 diabetic patients visiting primary healthcare clinics in Trinidad, West Indies. Scand J Prim Health Care 20(3): 177-82, 2002. |
[3] | Ezenwaka CE, Nwagbara E, Seales D, Okali F, Hussaini S, Raja Bn, et al. A comparative study of the prevalence of components of the metabolic syndrome in type 2 diabetic patients in two Caribbean Islands using the New International Diabetes Federation definition. Arch Physiol Biochem 113(4-5): 202-10, 2007. |
[4] | Ezenwaka C, Nwagbara E, Seales D, Okali F, Hussaini S, Raja Bn, et al. Prediction of 10-Year Coronary Heart Disease Risk in Caribbean Type 2 Diabetic Patients Using the UKPDS Risk Engine. Int J Cardiol 132: 348-353, 2009. |
[5] | Ezenwaka CE, Jones-Lecointe A, Nwagbara E, Seales D. Okali F. Anemia and kidney dysfunction in Caribbean type 2 diabetic patients. Cardiovasc Diabetol. 7:25, 2008. |
[6] | Soyibo AK, Barton EN. Chronic renal failure from the English-speaking Caribbean: 2007 data. West Indian Med J. 58(6): 596-600, 2009. |
[7] | Soyibo AK, Barton EN. Report from the Caribbean Renal Registry, 2006. West Indian Med J 56:355-63, 2007. |
[8] | Praga M, Hernández E, Herrero JC, Morales E, Revilla Y, Díaz-González R, et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58:2111-2118, 2000. |
[9] | Drafts HH, Anjum MR, Wynn JJ, Mulloy LL, Bowley JN, Humphries AL. The impact of pre-transplant obesity on renal transplant outcomes. Clin Transplant 11:493-496, 1997. |
[10] | Merion RM, Twork AM, Rosenberg L, Ham JM, Burtch GD, Turcotte JG, et al. Obesity and renal transplantation. Surg Gynecol Obstet 172:367-376, 1991. |
[11] | Meier-Kriesche HU, Vaghela M, Thambuganipalle R, Friedman G, Jacobs M, Kaplan B. The effect of body mass index on long-term renal allograft survival. Transplantation 68:1294-1297, 1999. |
[12] | Meier-Kriesche HU, Arndorfer JA, Kaplan B: The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death. Transplantation 73:70-74, 2002. |
[13] | Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezène F, et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 37: 720–727, 2001. |
[14] | Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12:1211-1217, 2001. |
[15] | Scaglione R, Ganguzza A, Corrao S, Parrinello G, Merlino G, Dichiara MA, et al. Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Int J Obes Relat Metab Disord 19:403-409, 1995. |
[16] | Ribstein J, Du CG, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 26:610-615, 1995. |
[17] | Reisin E, Messerli FG, Ventura HO, Frohlich ED. Renal haemodynamic studies in obesity hypertension. J Hypertens 5:397-400, 1987. |
[18] | Messerli FH, Christie B, DeCarvalho JG, Aristimuno GG, Suarez DH, Dreslinski GR et al. Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion and plasma renin activity. Arch Intern Med 141:81-85, 1981. |
[19] | Tucker BJ, Anderson CM, Thies RS, Collins RC, Blantz RC. Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. Kidney Int 42: 1160-1168, 1992. |
[20] | Bosma RJ, van der Heide JJH, Oosterop EJ, De Jong PE, Navis G. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 65:259-265, 2004. |
[21] | Anastasio P, Spitali L, Frangiosa A, Molino D, Stellato D, Cirillo E, et al. Glomerular filtration rate in severely overweight normotensive humans. AmJ Kidney Dis 35: 1144-1148, 2000. |
[22] | Porter LE, Hollenberg NK: Obesity, salt intake, and renal perfusion in healthy humans. Hypertension 32:144-148, 1998. |
[23] | Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 9:1498-1509, 2001. |
[24] | Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2:550-562, 2007. |
[25] | Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 3 (Supp.l):1-150, 2013. |
[26] | Kidney Disease Outcomes Quality Initiative (K/DOQI). Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Diseases 39:S1-S266, 2002. |
[27] | Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9): 604-612, 2009. |
[28] | Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23(5):469- 80, 2006. |
[29] | Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006. |
[30] | Kincaid-Smith P: Hypothesis: Obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labeled ‘hypertensive nephrosclerosis.’ J Hypertens 22: 1051-1055, 2004. |
[31] | Mungrue K, Ramdial S, Barran A, Lorinda B, Bridgelal A, Gildharie S et al. The epidemiology of end stage renal disease at a centre in Trinidad. West Indian Med J. 60(5):553-556, 2011. |
[32] | Janssen I, Katzmarzyk PT, Ross R: Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79: 379–384, 2004. |